In vivo expression of chimeric antigen receptors: using gene therapy to improve cell therapy 10 Aug 2023 Read More
Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022 19 Jul 2023 Read More
Does Green IP mean go? Exploring acceleration under the UKIPO’s “Green Channel” 18 Jul 2023 Read More
Evolution of engineered minimal cells - high mutation rates and regained fitness 13 Jul 2023 Read More
VC tips for SMEs — how much equity should a start-up give away in a Series A fundraising? 06 Jul 2023 Read More
.png)
.jpg)
.png)
